Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)

By Aus Gunnar   Becker Charlotte   Lilja Hans   Khatami Ali   Pihl Carl-Gustaf   Hugosson Jonas  

Scandinavian Journal of Urology and Nephrology, Vol. 37, Iss. 6, 2003-11 ,pp. : 466-470

Informa Healthcare

Access to resources Recommend Favorite

Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels

By Charlesworth M.C.   Young C.Y.-F.   Klee G.G.   Saedi M.S.   Mikolajczyk S.D.   Finlay J.A.   Tindall D.J.  

Urology, Vol. 49, Iss. 3, 1997-05 ,pp. : 487-493

Elsevier

Access to resources Recommend Favorite

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

By Magklara A.   Scorilas A.   Stephan C.   Kristiansen G.O.   Hauptmann S.   Jung K.   Diamandis E.P.  

Urology, Vol. 56, Iss. 3, 2000-09 ,pp. : 527-532

Elsevier

Access to resources Recommend Favorite

Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling

By Bridon D.P.   Dowell B.L.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 801-806

Elsevier

Access to resources Recommend Favorite

Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages

By Corey E.   Arfman E.W.   Oswin M.M.   Melchior S.W.   Tindall D.J.   Young C.Y.-F.   Ellis W.J.   Vessella R.L.  

Urology, Vol. 50, Iss. 2, 1997-08 ,pp. : 184-188

Elsevier

Access to resources Recommend Favorite